Mission Statement, Vision, & Core Values of BioLife Solutions, Inc. (BLFS)

Ever wondered what drives a company focused on revolutionizing regenerative medicine? What are the guiding principles behind their advancements in cell and gene therapy bioproduction? For BioLife Solutions, Inc. (BLFS), it all comes down to their mission, vision, and core values, which shape their strategic direction and daily operations. In 2024, BioLife Solutions reported total revenue of $82.3 million, marking an 8% increase from 2023, with cell processing revenue reaching $73.5 million, a 12% increase. Want to know how these values translate into real-world impact and financial growth? Read on to explore the foundational elements that steer this innovative company.

BioLife Solutions, Inc. (BLFS) An Overview of

BioLife Solutions, Inc. specializes in developing, manufacturing, and marketing biopreservation tools and services for cells, tissues, and organs. These products are vital for regenerative medicine, cell and gene therapy, and broader biopharmaceutical markets. Founded to address the critical need for improved preservation methods, the company has grown to become a key player in enabling the safe and effective storage and transport of biological materials.

As of April 2025, BioLife Solutions continues to provide a range of innovative solutions, including its CryoStor® and HypoThermosol® biopreservation media, which are designed to mitigate the adverse effects of freezing and thawing processes. These products help maintain the viability and functionality of biological samples, which is crucial for research, clinical applications, and commercial manufacturing. Additionally, the company offers a suite of equipment and services, such as freezers and cloud-based inventory management software, further supporting the biopreservation workflow.

In terms of financial performance, BioLife Solutions has demonstrated robust growth, driven largely by increasing demand for its biopreservation media in the expanding cell and gene therapy market. According to the latest financial reports from fiscal year 2024, the company achieved record-breaking revenue, with significant contributions from its biopreservation media sales. The company's strategic focus on innovation, combined with its ability to meet the stringent requirements of the biopharmaceutical industry, has solidified its position as a trusted partner. Recent expansions into new geographic markets and strategic acquisitions have further enhanced its growth trajectory.

BioLife Solutions stands out as a leader in the biopreservation industry due to its commitment to quality, innovation, and customer satisfaction. Its comprehensive portfolio of products and services addresses the critical needs of researchers, clinicians, and manufacturers involved in cell and gene therapy and regenerative medicine. Want to understand why BioLife Solutions is successful? Find out more BioLife Solutions, Inc. (BLFS): History, Ownership, Mission, How It Works & Makes Money.

BioLife Solutions, Inc. (BLFS) Mission Statement

BioLife Solutions, Inc. is dedicated to revolutionizing regenerative medicine, biobanking, and drug discovery by enhancing the viability of biologics. As a class-defining cell and gene therapy bioproduction tools and services company, BioLife Solutions aims to significantly improve the shelf life, post-preservation viability, and functionality of biological materials for life science companies and clinical researchers.

The company's mission reflects a commitment to serving its industry and customers, ensuring the viability of life-saving therapies. This dedication is evident in their continuous efforts to maintain the health and function of biological source material and finished products during manufacturing, storage, and distribution.

Here's a breakdown of the core components of BioLife Solutions' mission:

• Enhancing Viability: BioLife Solutions focuses on improving the shelf life and post-preservation viability of biological materials.
• Serving the Industry: The company is committed to supporting life science companies and clinical researchers.
• Ensuring Functionality: BioLife Solutions aims to maintain the health and function of biologics throughout the manufacturing, storage, and distribution processes.

BioLife Solutions operates on strong core values, emphasizing trust, commitment, and openness. These values are integrated into their products, customer service, contributions to the industry, and interactions among team members.

Trust is paramount at BioLife Solutions. Clients rely on the company to effectively fulfill their needs and manage risks, trusting their processes and products for storing and transporting valuable materials. BioLife Solutions aims to earn customers' trust and respect by delivering class-defining bioproduction solutions and helping them achieve their goals.

The company demonstrates its commitment to quality through ongoing efforts to maintain a culture of continuous improvement, ensuring they better serve their customers and the industry.

BioLife Solutions strives to be the leading provider of biopreservation tools for cells, tissues, and organs. The company facilitates basic and applied research and commercialization of new therapies by maintaining the health and function of biologic source material and finished products during manufacturing, distribution, and clinical administration.

BioLife Solutions aims to maintain financial performance consistent with maximizing shareholder value.

BioLife Solutions' vision is to grow with purpose, continually expanding and evolving to add tools and services that best serve customers' needs, always with their continued success in mind.

The company's solutions are utilized in numerous customer clinical applications.

BioLife Solutions fosters an inclusive culture where diverse perspectives are valued, and every team member is seen, heard, and respected.

In 2024, BioLife Solutions reported a total revenue of $82.3 million, an increase of 8% from $75.9 million in 2023. The Cell Processing platform revenue was $73.5 million, up 12% from 2023, while the Evo and Thaw platform revenue was $8.7 million, a decrease of 14% from 2023.

BioLife Solutions is introducing 2025 revenue guidance of $95.5 million to $99.0 million, representing growth of 16% to 20% compared with 2024. This is based on expectations for our Cell Processing platform and our evo and Thaw platform, as follows:

Seamlessly integrate the link without disrupting the flow of the content. Place this link in a format of BioLife Solutions, Inc. (BLFS): History, Ownership, Mission, How It Works & Makes Money

BioLife Solutions, Inc. (BLFS) Vision Statement of

BioLife Solutions, Inc. (BLFS) operates as a leading developer, manufacturer, and supplier of biopreservation tools and services for cells, tissues, and organs. Its mission focuses on enabling the advancement of cell and gene therapies by providing innovative solutions that improve the quality and consistency of these delicate biological materials. Understanding the company's vision and core values provides insight into its strategic direction and commitment to the life sciences industry. To delve deeper into the company's financial standing, check out this analysis: Breaking Down BioLife Solutions, Inc. (BLFS) Financial Health: Key Insights for Investors.

While specific long-term vision statements are subject to change, BioLife Solutions generally aims to be the leading provider in its niche. Key elements of their vision often revolve around:

• Advancing the field of cell and gene therapy.
• Providing comprehensive biopreservation solutions.
• Ensuring quality and reliability in biopreservation.

Below are the core elements that define BioLife Solutions, Inc. (BLFS) vision.

Advancing Cell and Gene Therapy

BioLife Solutions aims to be at the forefront of the cell and gene therapy revolution. This involves:

• Innovation: Continuously developing new and improved biopreservation tools and techniques to meet the evolving needs of the industry.
• Collaboration: Partnering with leading research institutions, biotech companies, and pharmaceutical firms to drive innovation and adoption of best practices.
• Education: Providing training and resources to help customers optimize their biopreservation processes and improve outcomes.

Comprehensive Biopreservation Solutions

The company seeks to offer a complete suite of products and services that cover the entire biopreservation workflow, including:

• Cryopreservation: Providing specialized freezing media like CryoStor® to protect cells during freezing and thawing.
• Cold Chain Management: Offering Stirling Ultracold freezers that ensure reliable and consistent ultra-low temperature storage.
• Thawing Solutions: Developing automated thawing devices like the ThawSTAR® system to standardize and optimize the thawing process.
• Transportation: Providing specialized packaging and transportation solutions to maintain the integrity of biological materials during shipping.

Quality and Reliability

BioLife Solutions emphasizes the importance of quality and reliability in biopreservation. This includes:

• Product Quality: Adhering to stringent quality control standards to ensure that products consistently meet or exceed customer expectations.
• Technical Support: Providing expert technical support to help customers troubleshoot issues and optimize their biopreservation protocols.
• Regulatory Compliance: Maintaining compliance with relevant regulatory requirements, such as those set by the FDA and EMA, to ensure the safety and efficacy of its products.

BioLife Solutions, Inc. (BLFS) Core Values of

While direct mentions of BioLife Solutions' mission statement, vision, and specific core values articulated for 2024/early 2025 are not available in the provided search results, we can analyze their operational focus and strategic initiatives to infer key values that drive the company. Based on available information, here are potential core values exemplified by BioLife Solutions:

Customer Focus and Solutions-Oriented Approach

BioLife Solutions appears deeply committed to meeting customer needs by providing innovative solutions in the biopreservation field. This is evident in their wide range of products, including biopreservation media, cryogenic freezers, and automated thawing devices. The company's focus on offering complete solutions suggests a customer-centric approach, aiming to improve the outcomes for cell and gene therapies. This dedication can be seen as a core value, emphasizing customer satisfaction through tailored and effective products.

Innovation and Technological Advancement

A strong emphasis on innovation is suggested by BioLife Solutions' development and marketing of advanced biopreservation tools and techniques. Their investment in research and development to enhance existing products and introduce new technologies highlights a commitment to staying at the forefront of the industry. This value of innovation is crucial in the rapidly evolving fields of cell and gene therapy, where better preservation methods can significantly impact therapeutic success.

• MICS™ (Medical Information Cloud Service): Showcases their innovation in providing secure, cloud-based platforms for managing critical medical information.
• evo® Smart LN2 Shipper: Highlights their focus on developing advanced cryogenic storage and transport solutions.

Quality and Reliability

Given the critical nature of biopreservation in cell and gene therapy, quality and reliability are likely central to BioLife Solutions' operations. The company's adherence to rigorous standards and focus on product validation would underscore a commitment to delivering dependable products. This emphasis on quality ensures that therapies are not compromised during preservation, reflecting a core value of ensuring patient safety and therapeutic efficacy.

• Stringent quality control processes to ensure product integrity
• Compliance with regulatory standards in biopreservation

Collaboration and Partnership

BioLife Solutions' business model, which involves supporting numerous cell and gene therapy companies, implies a value of collaboration and partnership. By working closely with therapy developers and researchers, the company contributes to the overall success of the field. This collaborative approach fosters innovation and helps drive the adoption of best practices in biopreservation.

These inferred values—Customer Focus, Innovation, Quality, and Collaboration—likely guide BioLife Solutions in its mission to support the advancement of cell and gene therapies. While this analysis is based on available information and industry context, a direct statement from the company would provide a more definitive understanding of their mission, vision, and core values as of 2024/early 2025.

To gain more insights into the financial aspects of BioLife Solutions, consider exploring: Breaking Down BioLife Solutions, Inc. (BLFS) Financial Health: Key Insights for Investors